Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Neurocrine Biosciences shares drop as trial failures may ‘stunt momentum,’ analysts say By: MarketWatch November 10, 2023 at 08:59 AM EST Company will halt development of experimental depression treatment Read More >> Related Stocks: Neurocrine Bioscienc Takeda Pharmaceutical Ltd ADR Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Neurocrine Biosciences shares drop as trial failures may ‘stunt momentum,’ analysts say By: MarketWatch November 10, 2023 at 08:59 AM EST Company will halt development of experimental depression treatment Read More >> Related Stocks: Neurocrine Bioscienc Takeda Pharmaceutical Ltd ADR